APA (7th ed.) Citation

VC, v. d. B., LER, K., EKSM, L., WM, K., WP, d. B., J, F., & SLAG, V. (2025). Molecular targeted treatment in infants with central conducting lymphatic anomalies. European journal of pediatrics, 184(9), 567. https://doi.org/10.1007/s00431-025-06376-2

Chicago Style (17th ed.) Citation

VC, van den Brink, Kleimeier LER, Leenders EKSM, Klein WM, de Boode WP, Fuijkschot J, and Vrancken SLAG. "Molecular Targeted Treatment in Infants with Central Conducting Lymphatic Anomalies." European Journal of Pediatrics 184, no. 9 (2025): 567. https://doi.org/10.1007/s00431-025-06376-2.

MLA (9th ed.) Citation

VC, van den Brink, et al. "Molecular Targeted Treatment in Infants with Central Conducting Lymphatic Anomalies." European Journal of Pediatrics, vol. 184, no. 9, 2025, p. 567, https://doi.org/10.1007/s00431-025-06376-2.